HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 04, April 2018 – Digestive health in the 21st century - Trust your guts       » Food wasted in China could feed 30-50 million       » Chinese scientists analyze human brain's "CPU"       » $150,000 fundraiser launched to sequence South Asian genomes       » Green tea-based drug carriers improve cancer treatment       » Scientists grow liver cancer cells in lab      
EYE ON CHINA
Ineffective baby vaccines by two companies recalled
Vaccines which immunize against diphtheria, pertussis (whooping cough) and tetanus were ineffective in its immunization effect but were not life-threatening.

More than 650,000 doses of a vaccine routinely given to newborns in China have been recalled after testing showed they were ineffective.

The problem with the vaccine, which immunizes against diphtheria, pertussis (whooping cough) and tetanus, was identified after batches were distributed in Shandong and Hebei provinces and in Chongqing.

Some doses were administered before the recall, "which might diminish the immunization effect but will not threaten people's health", the China Food and Drug Administration said in a statement on 3 November.

The recall relates to batches from two companies: Changsheng Biotechnology in Jilin province, which sent 252,600 doses to Shandong; and the Wuhan Institute of Biological Products in Hubei province, which sent 190,520 doses to Chongqing and 210,000 doses to Hebei.

Under the Drug Administration Law, vaccines must be checked for safety and efficacy before they can enter the market.

The National Institutes for Food and Drug Control, which carries out premarket checks, tested the DPT vaccines according to normal international practice, and reported no issues, the FDA said. However, the ineffective vaccines were not identified. A later routine check found the vaccines' "titer" - a measure of the concentration of antibodies-of both companies' products to be substandard.

Investigative teams have been sent to check compliance at the companies' production bases and will spend six to eight weeks testing the quality of all vaccines.

The National Health and Family Planning Commission and provincial health departments have also sent experts to assess stocks of the vaccine to ensure that routine immunization programs continue.

After the DPT vaccine was incorporated into China's immunization program in the 1970s, the rates of diphtheria, pertussis and tetanus have fallen steadily, according to the FDA.

"There has been no diphtheria cases reported since 2007, and the annual incidence of pertussis has dropped to less than 0.5 per 100,000 people now, compared with 100 to 200 per 100,000 in the 1970s," the statement said.

Source: China Daily

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Asthma / Dental health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy